Work

Prognostic Impact of Diabetes Status on Outcomes After Physiology-Guided Revascularization ― Insights From the J-PRIDE Registry ―

Year: 2026
Type: article
Study design: Observational Study
Abstract: BACKGROUND: The prognostic impact of diabetes status on outcomes after physiology-guided revascularization remains unclear. This study evaluated clinical outcomes in patients with insulin-treated diabetes (ITD), non-ITD (NITD), and without diabetes after physiology-guided revascularization. METHODS AND RESULTS: From the J-PRIDE registry, 3,140 patients were categorized into non-diabetes (n=1,797), NITD (n=1,133), and ITD (n=210) groups. The primary endpoint was the 1-year incidence of target vessel failure (TVF), a composite of cardiac death, target vessel-related myocardial infarction, and clinically driven target vessel revascularization. The 1-year TVF rate was significantly higher in the ITD and NITD groups than in the non-diabetes group (6.1% and 4.1% vs. 2.0%, respectively), with adjusted hazard ratios for the ITD and NTD groups of 2.14 (95% confidence interval [CI] 1.09-4.19; P=0.027) and 1.63 (95 CI 1.02-2.61; P=0.041), respectively. The non-hyperemic pressure ratio cut-off predicting fractional flow reserve (FFR) ≤0.80 was lower in the ITD than NITD and non-diabetes groups (0.87 vs. 0.89 and 0.90, respectively). The ITD group had the highest risk of TVF across all FFR values, followed by the NITD and non-diabetes groups. CONCLUSIONS: Patients with ITD and NITD exhibit worse clinical outcomes than those without diabetes. Notably, patients with ITD remained at elevated risk across the entire FFR spectrum, suggesting that physiological severity alone may not fully capture their residual cardiovascular risk.
Language: English
Field: Medicine
Open Access status: diamond
OpenAlex ID: W7222940496
FWCI:
Cites:
Cited by:
Related to: 10